Future Potential Clinical Applications of Spectroscopic Techniques in Human Diseases - Vibrational Spectroscopy for Tissue Analysis - page 302

4. Rehman, S., Movasaghi, Z., Darr, J. A., and Rehman, I. U. 2010. Fourier trans-
form infrared spectroscopic analysis of breast cancer tissues: Identifying differ-
ences between normal breast, invasive ductal carcinoma and ductal carcinoma
in situ of the breast. Appl. Spectrosc. Rev . 45, 355-368.
5. Luyten, P. R., Marien, A. J. H., Heindel, W., Gerwen, P. H. V., Herholz, K.,
Hollander, J. A. D., Friedmann, G., and Heiss, W. D. 1990. Metabolic imaging
of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET.
Radiology 176, 791-799.
6. Bruhn, H., Frahm, J., Gyngell, M. L., Merboldt, K. D., Hanicke, W., Sauter, R. and
Hamburger, C. 1989. Noninvasive differentiation of tumors with use of local-
ized H-1 MR spectroscopy in vivo: Initial experience in patients with cerebral
tumors. Radiology 172, 541-548.
7. Gill, S. S., Thomas, D. G., Van Bruggen, N., Gadian, D. G., Peden, C. J., Bell
J. D., Cox, I. J., Menon, D. K., Iles, R. A., and Bryant, D. J. 1990. Proton MR spec-
troscopy of intracranial tumors: In vivo and in vitro studies. J. Comput. Assist.
Tomogr . 14, 497-504.
8. Fulham, M. J., Bizzi, A., Dietz, M. J., Shih, H. H., Raman, R., Sobering, G. S.,
Frank, J. A., Dwyer, A. J., Alger J. R., and Di Chiro, G. 1992. Mapping of brain
tumor metabolites with proton MR spectroscopic imaging: Clinical relevance.
Radiology 185, 675-686.
9. Demaerel, P., Johannik, K., Van Hecke, P., Van Ongeval, C., Verellen, S., Marchal,
G., Wilms, G., Plets, C., Goffin, J., and Van Calenbergh, F. 1991. Localized H-1
NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors.
J. Comput. Assist. Tomogr . 15, 67-76.
10. Miller, B. L. 1991. A review of chemical issues in 1H NMR spectroscopy:
N-acetyl-L-aspartate, creatine, and choline. NMR Biomed . 4, 47-52.
11. Kugel, H., Heindel, W., Ernestus, R. I., Bunke, J., du Mesnil, R. and Friedmann,
G. 1992. Human brain tumors: Spectral patterns detected with localized H-1 MR
spectroscopy. Radiology 183, 701-709.
12. Bruhn, H., Frahm, J., Gyngell, M. L., Merboldt, K. D., Hanicke, W., Sauter, R.,
and Hamburger, C. 1989. Noninvasive differentiation of tumors with use of
localized H-1 MR spectroscopy in vivo: Initial experience in patients with cere-
bral tumors. Radiology 172, 541-548.
13. Shonk, T. K., Moats, R. A., Gifford, P., Michaelis, T., Mandigo, J. C., Izumi, J.,
and Ross, B. D. 1995. Probable Alzheimer disease: Diagnosis with proton MR
spectroscopy. Radiology 195, 65-72.
14. Miller, B. L., Moats, R. A., Shonk, T., Ernst, T., Woolley, S., and Ross, B. D. 1993.
Alzheimer disease: Depiction of increased cerebral myo-inositol with proton
MR spectroscopy. Radiology 187, 433-437.
15. Belshaw, N. J., Elliott, G. O., Foxall, R. J., Dainty, J. R., Pal, N., Coupe, A., Garg,
D., Bradburn, D. M., Mathers, J. C., and Johnson, I. T. 2008. Profiling CpG island
field methylation in both morphologically normal and neoplastic human colonic
mucosa. Br. J. Cancer . 99, 136-142.
16. Miller, W. T. 1990. Value of clinical history. AJR Am. J. Roentgenol . 155, 653-654.
17. Swensen, S. J., Brown, L. R., and Colby, T. V. 1996. Lung nodule enhancement at
CT: Prospective findings. Radiology 201, 447-455.
18. Hellwig, D., Baum, R. P., and Kirsch, C. 2009. FDG-PET, PET/CT and conven-
tional nuclear medicine procedures in the evaluation of lung cancer: A system-
atic review. Nuklearmedizin 48, 59-69.